Article info
Basic Science
Deregulation of miR-128 in Ovarian Cancer Promotes Cisplatin Resistance
- Address correspondence and reprint requests to Li-Xin Shang, MD, Department of Gynecology and Obstetrics, the Military General Hospital of Beijing PLA, No. 5, Nanmencang, Dongcheng District, Beijing, 100700, China. E-mail: 601847608{at}qq.com.
Citation
Deregulation of miR-128 in Ovarian Cancer Promotes Cisplatin Resistance
Publication history
- Received May 7, 2014
- Accepted August 3, 2014
- First published October 1, 2014.
Online issue publication
February 25, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2014 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.